169 related articles for article (PubMed ID: 10921445)
1. Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levels.
Kenny AM; Prestwood KM; Raisz LG
Endocr Res; 2000 May; 26(2):153-68. PubMed ID: 10921445
[TBL] [Abstract][Full Text] [Related]
2. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
[TBL] [Abstract][Full Text] [Related]
3. Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels.
Kenny AM; Bellantonio S; Gruman CA; Acosta RD; Prestwood KM
J Gerontol A Biol Sci Med Sci; 2002 May; 57(5):M321-5. PubMed ID: 11983727
[TBL] [Abstract][Full Text] [Related]
4. The effect of short-term treatment with micronized estradiol on bone turnover and gonadotrophins in older men.
Taxel P; Kennedy D; Fall P; Willard A; Shoukri K; Clive J; Raisz LG
Endocr Res; 2000 Aug; 26(3):381-98. PubMed ID: 11019903
[TBL] [Abstract][Full Text] [Related]
5. Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.
Zgliczynski S; Ossowski M; Slowinska-Srzednicka J; Brzezinska A; Zgliczynski W; Soszynski P; Chotkowska E; Srzednicki M; Sadowski Z
Atherosclerosis; 1996 Mar; 121(1):35-43. PubMed ID: 8678922
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men.
Dobs AS; Meikle AW; Arver S; Sanders SW; Caramelli KE; Mazer NA
J Clin Endocrinol Metab; 1999 Oct; 84(10):3469-78. PubMed ID: 10522982
[TBL] [Abstract][Full Text] [Related]
7. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
[TBL] [Abstract][Full Text] [Related]
10. The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer.
Taxel P; Fall PM; Albertsen PC; Dowsett RD; Trahiotis M; Zimmerman J; Ohannessian C; Raisz LG
J Clin Endocrinol Metab; 2002 Nov; 87(11):4907-13. PubMed ID: 12414849
[TBL] [Abstract][Full Text] [Related]
11. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD
J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Hematocrit Change in Testosterone-deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial.
Rivero MJ; Ory J; Diaz P; Thirumavalavan N; Han S; Reis IM; Ramasamy R
J Urol; 2023 Jul; 210(1):162-170. PubMed ID: 37126399
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.
Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS
J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600
[TBL] [Abstract][Full Text] [Related]
14. Effects of testosterone supplementation in the aging male.
Tenover JS
J Clin Endocrinol Metab; 1992 Oct; 75(4):1092-8. PubMed ID: 1400877
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
Raynaud JP; Gardette J; Rollet J; Legros JJ
BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
[TBL] [Abstract][Full Text] [Related]
16. [The influence of testosterone replacement therapy on well-being, bone mineral density and lipids in elderly men].
Rabijewski M; Adamkiewicz M; Zgliczyński S
Pol Arch Med Wewn; 1998 Sep; 100(3):212-21. PubMed ID: 10335026
[TBL] [Abstract][Full Text] [Related]
17. Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels.
Kenny AM; Prestwood KM; Gruman CA; Fabregas G; Biskup B; Mansoor G
J Gerontol A Biol Sci Med Sci; 2002 Jul; 57(7):M460-5. PubMed ID: 12084809
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
Uebelhart B; Herrmann F; Pavo I; Draper MW; Rizzoli R
J Bone Miner Res; 2004 Sep; 19(9):1518-24. PubMed ID: 15312253
[TBL] [Abstract][Full Text] [Related]
19. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years.
Behre HM; von Eckardstein S; Kliesch S; Nieschlag E
Clin Endocrinol (Oxf); 1999 May; 50(5):629-35. PubMed ID: 10468929
[TBL] [Abstract][Full Text] [Related]
20. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
